Kyte, J. A., Røssevold, A., Falk, R. S., & Naume, B. (2020). ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer. J Transl Med.
Citación estilo ChicagoKyte, J. A., A. Røssevold, R. S. Falk, and B. Naume. "ALICE: A Randomized Placebo-controlled Phase II Study Evaluating Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer." J Transl Med 2020.
Cita MLAKyte, J. A., A. Røssevold, R. S. Falk, and B. Naume. "ALICE: A Randomized Placebo-controlled Phase II Study Evaluating Atezolizumab Combined With Immunogenic Chemotherapy in Patients With Metastatic Triple-negative Breast Cancer." J Transl Med 2020.